http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180096407-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55a854abe5a37b075d9a25a1cfcb46eb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555
filingDate 2017-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6e66964f3e0a16388a17fe49135dc59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d659f7d1ea12809eb01706c7e9841aad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c38b4c809021a6cc8eb816f87b3cd162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7563a236a80ce0343754413fce479165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8114a89f24a70980acb06056768f7497
publicationDate 2018-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20180096407-A
titleOfInvention Pharmaceutical composition for treating cancer with suppressed side effects in the immune system
abstract The present invention relates to a pharmaceutical composition for cancer treatment comprising coumarin or a pharmaceutically acceptable salt thereof as an active ingredient capable of preventing or treating immune system side effects induced by an anti-cancer agent, a pharmaceutical composition for the treatment of cancer which comprises coumarin or a pharmaceutically acceptable salt thereof and an anti- , A pharmaceutical composition for treating cancer in which side effects are suppressed and safety is increased and a health functional food for preventing or ameliorating side effects of the immune system induced by an anticancer agent containing coumarin or a pharmaceutically acceptable salt thereof as an active ingredient &Lt; / RTI &gt; The coumarin provided by the present invention can reduce the immune system side effects caused by administration of various platinic anticancer drugs, and thus can be widely used for safe cancer treatment using platinic anticancer drugs.
priorityDate 2017-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID128608
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21926
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221067
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID744399
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918840
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583147
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397086
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25199580
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453197090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322421
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID55670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323297
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451431471
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14982
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID554167
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6857599
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415133005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441203
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID85712
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID128608
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134169138
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID55670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448612181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526595
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86591708
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535155
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100126739
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID494186
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID323
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID114461
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426122658
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7124
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID85712
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124604970
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID36054
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071

Total number of triples: 83.